Original Research
Accepted on 26 Dec 2024
Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1510988
Type at least 3 characters
928 articles
Articles
Review
Accepted on 24 Dec 2024
Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1511301
Systematic Review
Published on 24 Dec 2024
Efficacy and safety of camrelizumab for the treatment of cervical cancer: a systematic review and meta-analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1526103
- 201 views
Brief Research Report
Published on 24 Dec 2024
Exploring the role of Epstein-Barr virus infection on the clinical features and survival in locally advanced cervical cancer: a retrospective cohort study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1522244
- 117 views
Systematic Review
Published on 23 Dec 2024
Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1461175
- 111 views
Original Research
Accepted on 20 Dec 2024
HLA-DMB Correlates With Antitumor Immunity and an Improved Prognosis in Endometrial Carcinoma Tumors
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1525601
Case Report
Published on 20 Dec 2024
A case report and literature review: leiomyosarcoma or perivascular epithelioid cell neoplasm?
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1499403
- 203 views
Case Report
Published on 20 Dec 2024
Case report: High-grade serous tubo-ovarian carcinoma with FGFR2::IQCG fusion and insights into targetability
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1514471
- 198 views
Original Research
Accepted on 18 Dec 2024
Survival Analysis of Recurrent Ovarian Cancer under Different PARP Inhibitor Treatment Patterns: A Single-Center Retrospective Study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1504084
Case Report
Published on 18 Dec 2024
Primary uterine non-Hodgkin’s lymphoma:a rare case report and review of the literature
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1462353
- 217 views
Review
Accepted on 17 Dec 2024
The Diagnostic Performance of International Ovarian Tumor Analysis-Simple Rules for Diagnosing Ovarian Tumors: A Systematic Review and Meta-Analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1474930
Correction
Accepted on 17 Dec 2024
Corrigendum: DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration via inhibition of the Wnt pathway and EMT in cervical cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1545180
Systematic Review
Accepted on 16 Dec 2024
Nanoparticles in gynecologic cancers: a bibliometric and visualization analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1465987
Systematic Review
Accepted on 16 Dec 2024
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1524991
Systematic Review
Published on 16 Dec 2024
Effectiveness of continuity of care in postoperative patients with cervical cancer: a systematic evaluation and meta-analysis of a randomized controlled trial
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1461296
- 154 views
Systematic Review
Accepted on 13 Dec 2024
Prognostic and diagnostic value of circRNA expression in cervical cancer: A meta analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1488040